Insufficient Screening for Childhood Cancer Survivors

Article

A survey of oncologists reveals that few are aware of surveillance recommendations.

At the annual meeting of the American Society of Clinical Oncology (ASCO) in early June 2010, a poster was presented that described the results of oncologists' knowledge of surveillance recommendations for childhood cancer survivors. The principal investigator, Dr. Tara Henderson of the University of Chicago, mailed surveys to 1,249 medical oncologists in the USA who had been systematically selected from the 2009 ASCO directory. Of the 497 surveys that were returned, 47% were from physicians in private practice, 32% from physicians in academic medical centers, and 17% were from physicians working in cancer centers. The median time in clinical practice was almost 20 years, so the physicians who responded were not new to oncology. The physicians were asked three questions about surveillance recommendations, based on Children's Oncology Group (COG) guidelines. Most of the physicians responding (85%) did not appropriately recommend cardiac surveillance, 55% did not appropriately recommend yearly thyroid surveillance, 45% did not appropriately recommend yearly breast cancer surveillance, and only 5% answered all three questions appropriately.

Education of oncologists about long-term care of childhood cancer survivors is needed, and hopefully the results of this survey will raise oncologists' awareness of gaps in knowledge and encourage them to learn more about this important area of practice.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.